Skip to main content

Advertisement

SpringerLink
Log in

Endothelin-1 Reduces P-Glycoprotein Transport Activity in an In Vitro Model of Human Adult Blood–brain Barrier

  • Brief Communication
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Aims It is a huge challenge to understand the blood–brain barrier (BBB), which is a key element in neuroinflammation associated with many brain diseases. The BBB also regulates the passage of xenobiotics into the central nervous system (CNS), and therefore influences drug efficacy. This may be due to the presence of ATP binding cassette transporters such as P-glycoprotein (Pgp) on the BBB, which are efflux pumps known to transport many drugs. The peptide endothelin 1 (ET-1) is involved in different kinds of CNS diseases and neuroinflammation, and is known to modulate Pgp transport activity. Although there are data from animal models, data from human models are scarce. We evaluated Pgp expression and transport activity in adult human brain microvascular endothelial cells (HBMECs) when exposing an adult human in vitro BBB model to ET-1. Methods Adult HBMECs were cocultured with human adult glial cells on a TranswellsR to mimic blood and CNS compartments. These human in vitro BBBs were exposed for 24 h to 100 nM and 10 nM ET-1. Pgp expression was assessed by flow cytometry and its transport activity by measuring radiolabelled digoxin passage. Results After exposure to ET-1, flow cytometry showed no shift of fluorescence intensity for a Pgp specific antibody. The passage of digoxin increased with a significant decrease of Q ratio for 10 nM ET-1. Conclusion Our results show that ET-1 has no effect on Pgp expression of adult HBMECs, but does modulate Pgp transport activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  • Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730–732

    Article  PubMed  CAS  Google Scholar 

  • Bagnato A, Rosano L, Spinella F, Di Castro V, Tecce R, Natali PG (2004) Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression. Cancer Res 64:1436–1443

    Article  PubMed  CAS  Google Scholar 

  • Ballabh P, Braun A, Nedergaard M (2004) The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16:1–13

    Article  PubMed  CAS  Google Scholar 

  • Barone FC, Willette RN, Yue TL, Feurestein G (1995) Therapeutic effects of endothelin receptor antagonists in stroke. Neurol Res 17:259–264

    PubMed  CAS  Google Scholar 

  • Bauer B, Hartz AM, Miller DS (2007) Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol Pharmacol 71:667–675

    Article  PubMed  CAS  Google Scholar 

  • Chauhan A, Hahn S, Gartner S, Pardo CA, Netesan SK, McArthur J, Nath A (2007) Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins. FASEB J 21:777–789

    Article  PubMed  CAS  Google Scholar 

  • Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, Jiang H, Prior JL, Sagare A, Bales KR, Paul SM, Zlokovic BV, Piwnica-Worms D, Holtzman DM (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 115:3285–3290

    Article  PubMed  CAS  Google Scholar 

  • Cordon-Cardo C, O’Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86:695–698

    Article  PubMed  CAS  Google Scholar 

  • de Vries HE, Kuiper J, de Boer AG, Van Berkel TJ, Breimer DD (1997) The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev 49:143–155

    PubMed  Google Scholar 

  • Didier N, Banks WA, Creminon C, Reuddre-Bosquet N, Mabondzo A (2002) HIV-1-induced production of endothelin-1 in an in vitro model of the human blood-brain barrier. Neuroreport 13:1179–1183

    Article  PubMed  CAS  Google Scholar 

  • Didier N, Romero IA, Creminon C, Wijkhuisen A, Grassi J, Mabondzo A (2003) Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability. J Neurochem 86:246–254

    Article  PubMed  CAS  Google Scholar 

  • Ehrenreich H, Costa T, Clouse KA, Pluta RM, Ogino Y, Coligan JE, Burd PR (1993) Thrombin is a regulator of astrocytic endothelin-1. Brain Res 600:201–207

    Article  PubMed  CAS  Google Scholar 

  • Fernandez C, Buyse M, German-Fattal M, Gimenez F (2004) Influence of the pro-inflammatory cytokines on P-glycoprotein expression and functionality. J Pharm Pharm Sci 7:359–371

    PubMed  CAS  Google Scholar 

  • Goralski KB, Hartmann G, Piquette-Miller M, Renton KW (2003) Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br J Pharmacol 139:35–48

    Article  PubMed  CAS  Google Scholar 

  • Hagenbuch B, Gao B, Meier PJ (2002) Transport of xenobiotics across the blood-brain barrier. News Physiol Sci 17:231–234

    PubMed  CAS  Google Scholar 

  • Hartz AM, Bauer B, Fricker G, Miller DS (2004) Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1. Mol Pharmacol 66:387–394

    Article  PubMed  CAS  Google Scholar 

  • Hawkins RA, O’Kane RL, Simpson IA, Vina JR (2006) Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr 136:218S–226S

    PubMed  CAS  Google Scholar 

  • Hebert VY, Crenshaw BL, Romanoff RL, Ekshyyan VP, Dugas TR (2004) Effects of HIV drug combinations on endothelin-1 and vascular cell proliferation. Cardiovasc Toxicol 4:117–131

    Article  PubMed  CAS  Google Scholar 

  • Jiang B, Hebert VY, Zavecz JH, Dugas TR (2006) Antiretrovirals induce direct endothelial dysfunction in vivo. J Acquir Immune Defic Syndr 42:391–395

    Article  PubMed  CAS  Google Scholar 

  • Josserand V, Pelerin H, de Bruin B, Jego B, Kuhnast B, Hinnen F, Duconge F, Boisgard R, Beuvon F, Chassoux F, umas-Duport C, Ezan E, Dolle F, Mabondzo A, Tavitian B (2006) Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier. J Pharmacol Exp Ther 316:79–86

    Article  PubMed  CAS  Google Scholar 

  • Kim JH, Kim JH, Park JA, Lee SW, Kim WJ, Yu YS, Kim KW (2006) Blood-neural barrier: intercellular communication at glio-vascular interface. J Biochem Mol Biol 39:339–345

    PubMed  CAS  Google Scholar 

  • Kodawara T, Masuda S, Wakasugi H, Uwai Y, Futami T, Saito H, Abe T, Inu K (2002) Organic anion transporter oatp2-mediated interaction between digoxin and amiodarone in the rat liver. Pharm Res 19:738–743

    Article  PubMed  CAS  Google Scholar 

  • Loscher W, Potschka H (2005a) Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 6:591–602

    Article  PubMed  CAS  Google Scholar 

  • Loscher W, Potschka H (2005b) Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog Neurobiol 76:22–76

    Article  PubMed  CAS  Google Scholar 

  • Mangahas CR, la Cruz GV, Friedman-Jimenez G, Jamal S (2005) Endothelin-1 induces CXCL1 and CXCL8 secretion in human melanoma cells. J Invest Dermatol 125:307–311

    PubMed  CAS  Google Scholar 

  • Megard I, Garrigues A, Orlowski S, Jorajuria S, Clayette P, Ezan E, Mabondzo A (2002) A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo-in vitro correlation. Brain Res 927:153–167

    Article  PubMed  CAS  Google Scholar 

  • Mikkaichi T, Suzuki T, Onogawa T, Tanemoto M, Mizutamari H, Okada M, Chaki T, Masuda S, Tokui T, Eto N, Abe M, Satoh F, Unno M, Hishinuma T, Inui K, Ito S, Goto J, Abe T (2004) Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. Proc Natl Acad Sci USA 101:3569–3574

    Article  PubMed  CAS  Google Scholar 

  • Milane A, Fernandez C, Vautier S, Bensimon G, Meininger V, Farinotti R (2007) Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier. J Neurochem 103:164–173

    PubMed  CAS  Google Scholar 

  • Morgan ET, Goralski KB, Piquette-Miller M, Renton KW, Robertson GR, Chaluvadi MR, Charles KA, Clarke SJ, Kacevska M, Liddle C, Richardson TA, Sharma R, Sinal CJ (2008) Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos 36:205–216

    Article  PubMed  CAS  Google Scholar 

  • Nakajima M, Morimoto S, Takamoto S, Kitano S, Fukuo K, Onishi T, Ogihara T (1994) Endothelin-1 in cerebrospinal fluid in elderly patients with hypertension and dementia. Hypertension 24:97–100

    PubMed  CAS  Google Scholar 

  • Nie XJ, Olsson Y (1996) Endothelin peptides in brain diseases. Rev Neurosci 7:177–186

    PubMed  CAS  Google Scholar 

  • Pardridge WM (2007) Blood-brain barrier delivery. Drug Discov Today 12:54–61

    Article  PubMed  CAS  Google Scholar 

  • Polli JW, Jarrett JL, Studenberg SD, Humphreys JE, Dennis SW, Brouwer KR, Woolley JL (1999) Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor. Pharm Res 16:1206–1212

    Article  PubMed  CAS  Google Scholar 

  • Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, Reuddre-Bosquet N, Dormont D, Gras G (2005) Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 142:481–489

    PubMed  CAS  Google Scholar 

  • Rautio J, Humphreys JE, Webster LO, Balakrishnan A, Keogh JP, Kunta JR, Serabjit-Singh CJ, Polli JW (2006) In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates. Drug Metab Dispos 34:786–792

    Article  PubMed  CAS  Google Scholar 

  • Rolinski B, Heigermoser A, Lederer E, Bogner JR, Loch O, Goebel FD (1999) Endothelin-1 is elevated in the cerebrospinal fluid of HIV-infected patients with encephalopathy. Infection 27:244–247

    Article  PubMed  CAS  Google Scholar 

  • Ronaldson PT, Bendayan R (2006) HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein. Mol Pharmacol 70:1087–1098

    Article  PubMed  CAS  Google Scholar 

  • Saengkhae C, Salerno M, Ades D, Siove A, Le Moyeca L, Migonney V, Garnier-Suillerot A (2007) Ability of carbazole salts, inhibitors of Alzheimer beta-amyloid fibril formation, to cross cellular membranes. Eur J Pharmacol 559:124–131

    Article  PubMed  CAS  Google Scholar 

  • Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T (1990) Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732–735

    Article  PubMed  CAS  Google Scholar 

  • Sasaki Y, Takimoto M, Oda K, Fruh T, Takai M, Okada T, Hori S (1997) Endothelin evokes efflux of glutamate in cultures of rat astrocytes. J Neurochem 68:2194–2200

    Article  PubMed  CAS  Google Scholar 

  • Schinelli S (2006) Pharmacology and physiopathology of the brain endothelin system: an overview. Curr Med Chem 13:627–638

    Article  PubMed  CAS  Google Scholar 

  • Schwartz M, Butovsky O, Kipnis J (2006) Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy. J Neuroimmune Pharmacol 1:4–10

    Article  PubMed  Google Scholar 

  • Shirakami G, Nakao K, Saito Y, Magaribuchi T, Mukoyama M, Arai H, Hosoda K, Suga S, Mori K, Imura H (1993) Low doses of endothelin-1 inhibit atrial natriuretic peptide secretion. Endocrinology 132:1905–1912

    Article  PubMed  CAS  Google Scholar 

  • Speciale L, Sarasella M, Ruzzante S, Caputo D, Mancuso R, Calvo MG, Guerini FR, Ferrante P (2000) Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis. J Neurovirol 6(Suppl 2):S62–S66

    PubMed  CAS  Google Scholar 

  • Suzuki R, Masaoka H, Hirata Y, Marumo F, Isotani E, Hirakawa K (1992) The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 77:96–100

    Article  PubMed  CAS  Google Scholar 

  • Takuwa Y, Yanagisawa M, Takuwa N, Masaki T (1989) Endothelin, its diverse biological activities and mechanisms of action. Prog Growth Factor Res 1:195–206

    Article  PubMed  CAS  Google Scholar 

  • Tansey MG, Frank-Cannon TC, McCoy MK, Lee JK, Martinez TN, McAlpine FE, Ruhn KA, Tran TA (2008) Neuroinflammation in Parkinson’s disease: is there sufficient evidence for mechanism-based interventional therapy? Front Biosci 13:709–717

    Article  PubMed  CAS  Google Scholar 

  • Tatsuta T, Naito M, Oh-hara T, Sugawara I, Tsuruo T (1992) Functional involvement of P-glycoprotein in blood-brain barrier. J Biol Chem 267:20383–20391

    PubMed  CAS  Google Scholar 

  • Theron D, de Barraud LS, Tardivel S, Pelerin H, Demeuse P, Mercier C, Mabondzo A, Farinotti R, Lacour B, Roux F, Gimenez F (2003) Influence of tumor necrosis factor-alpha on the expression and function of P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT. Biochem Pharmacol 66:579–587

    Article  PubMed  CAS  Google Scholar 

  • Uhr M, Ebinger M, Rosenhagen MC, Grauer MT (2005) The anti-Parkinson drug budipine is exported actively out of the brain by P-glycoprotein in mice. Neurosci Lett 383:73–76

    Article  PubMed  CAS  Google Scholar 

  • Wright CE, Fozard JR (1988) Regional vasodilation is a prominent feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats. Eur J Pharmacol 155:201–203

    Article  PubMed  CAS  Google Scholar 

  • Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415

    Article  PubMed  CAS  Google Scholar 

  • Yoshimoto S, Ishizaki Y, Kurihara H, Sasaki T, Yoshizumi M, Yanagisawa M, Yazaki Y, Masaki T, Takakura K, Murota S (1990) Cerebral microvessel endothelium is producing endothelin. Brain Res 508:283–285

    Article  PubMed  CAS  Google Scholar 

  • Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M (1992) Increased plasma endothelin-1 in acute ischemic stroke. Stroke 23:1014–1016

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank the ANRS (Agence Nationale de Recherche sur le SIDA) for financial support. We would also like to thank Gabriel Gras (CEA Fontenay-aux-Roses, France) and Jean-François Heilier (Université Catholique de Louvain, Belgium) for their advice in statistics.

Author information

Authors and Affiliations

  1. iBiTec-S (Institut de biologie et technologies de Saclay), SPI (Service de Pharmacologie et Immunoanalyse), LEMM (Laboratoire d’Etudes du Métabolisme des Médicaments), CEA Saclay, 91191, Gif-sur-Yvette Cedex, France

    Alexandra Hembury & Aloïse Mabondzo

Authors
  1. Alexandra Hembury
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aloïse Mabondzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aloïse Mabondzo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hembury, A., Mabondzo, A. Endothelin-1 Reduces P-Glycoprotein Transport Activity in an In Vitro Model of Human Adult Blood–brain Barrier. Cell Mol Neurobiol 28, 915–921 (2008). https://doi.org/10.1007/s10571-008-9277-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-008-9277-y

Keywords

Search

Navigation